Acute Kidney Injury and Bisphosphonate Use in Cancer: A Report From the Research on Adverse Drug Events and Reports (RADAR) Project

PURPOSE: To determine whether acute kidney injury (AKI) is identified within the US Food and Drug Administration's Adverse Events and Reporting System (FDA AERS) as an adverse event resulting from bisphosphonate (BP) use in cancer therapy. METHODS: A search of the FDA AERS records from January...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Edwards, Beatrice J., Usmani, Sarah, Raisch, Dennis W., McKoy, June M., Samaras, Athena T., Belknap, Steven M., Trifilio, Steven M., Hahr, Allison, Bunta, Andrew D., Abu-Alfa, Ali, Langman, Craig B., Rosen, Steve T., West, Dennis P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2013
Assuntos:
Health Policy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3595436/
https://ncbi.nlm.nih.gov/pubmed/23814519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2011.000486
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados